How will the pandemic affect sight-saving research in the long term?
Aleksandra Jones | | Opinion
The global impact of pandemic mitigation measures on research has been immense – and vision science research is no exception. Social distancing and lockdowns have meant that most scientific research and clinical trials have been inevitably delayed, with researchers unable to either take their work home or carry it out in their usual settings. In the UK, 70 percent of clinical trials and studies have been paused, delayed, or stopped (1), with some institutions halting all but COVID-19-related and life-saving research (2).
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.